Table A1. Chemotherapy regimens in use.

	n
Doxorubicin/cyclophosphamide six cycles	41
Doxorubicin/docetaxel six cycles	21
Epirubicin four cycles then CMF four cycles	2
Epirubicin four cycles	2
Docetaxel/Herceptin	1
Total	67

Clinical trials (1997–2003): Anglo-Celtic 2 Study: doxorubicin/cyclophosphamide vs doxorubicin/docetaxel six cycles (Evans et al, 2002). _ Docetaxel/Herceptin expanded access phase 4 assessment (Howell et al, 2002). Standard off study treatment: doxorubicin/cyclophosphamide six cycles.